08:35 EST Tango Therapeutics (TNGX) files to sell 1.73M shares of common stock for holders
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNGX:
- Perspective Therapeutics price target lowered to $11 from $12 at B. Riley
- Tango Therapeutics price target raised to $14 from $8 at B. Riley
- Tango Therapeutics initiated with a Peer Perform at Wolfe Research
- Tango Therapeutics Reports Promising Q3 2025 Results
- Tango Therapeutics reports Q3 EPS 14c, consensus (7c)